Oramed Pharmaceuticals Inc(NASDAQ:ORMP) 
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, ...
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 2.15
H 2.19
L 2.07
C 2.10
V 102,058
10EMA 2.10
20EMA 2.10
60EMA 2.10
120EMA 2.10
250EMA 2.10